Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 4/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.44 |
| ▸ | CHAT | P28329 | 3/20 | 0.40 |
| ▸ | DPYD | Q12882 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 2/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2301397 | 1.00 | NFE2L2 (0.44) | NFE2L2TRPA1CHATDPYDMAOB | |
| SCHEMBL2033487 | 0.87 | NFE2L2 (0.54) | NFE2L2TRPA1CHATMAOBCYP19A1 | |
| SCHEMBL2033485 | 0.87 | NFE2L2 (0.54) | NFE2L2TRPA1CHATMAOBCYP19A1 | |
| SCHEMBL3363528 | 0.78 | NFE2L2 (0.45) | NFE2L2TRPA1CHATMAOBCYP19A1 | |
| SCHEMBL478037 | 0.76 | NFE2L2 (0.58) | NFE2L2TRPA1CHATMAOBCYP19A1 | |
| SCHEMBL478036 | 0.76 | NFE2L2 (0.58) | NFE2L2TRPA1CHATMAOBCYP19A1 | |
| SCHEMBL41525 | 0.76 | TRPA1 (0.59) | NFE2L2TRPA1CHATMAOBALOX5 | |
| SCHEMBL41526 | 0.76 | TRPA1 (0.59) | NFE2L2TRPA1CHATMAOBALOX5 | |
| SCHEMBL29360472 | 0.76 | TRPA1 (0.59) | NFE2L2TRPA1CHATMAOBALOX5 | |
| Formaldehyde SCHEMBL28642478 | 0.76 | TRPA1 (0.53) | NFE2L2TRPA1CHATALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109354672-B | Alkylene oxide urethane associative thickeners modified with hydrophobic oligomers | 罗门哈斯公司 | 2021-10-15 | — | — | CN | claimed |
| US-20240041043-A1 | STORAGE STABLE AQUEOUS SUSPENSION CONCENTRATES | Bayer Vapi Private Limited (IN) | 2024-02-08 | — | — | US | disclosed |
| CN-116828985-A | Storage-stable aqueous suspension concentrates | 拜耳公司 | 2023-09-29 | — | — | CN | disclosed |
| WO-2022128955-A1 | STORAGE STABLE AQUEOUS SUSPENSION CONCENTRATES | BAYER AKTIENGESELLSCHAFT (DE) | 2022-06-23 | — | — | WO | disclosed |
| EP-4011209-A1 | STORAGE STABLE AQUEOUS SUSPENSION CONCENTRATES | Bayer Aktiengesellschaft (DE) | 2022-06-15 | — | — | EP | disclosed |
| CN-109354672-B | Alkylene oxide urethane associative thickeners modified with hydrophobic oligomers | 罗门哈斯公司 | 2021-10-15 | — | — | CN | disclosed |
| CN-107519040-B | Clear suspended personal care cleansing compositions | 强生消费者公司 | 2021-10-08 | — | — | CN | disclosed |
| EP-3697221-A1 | AQUEOUS [2-(2,4-DICHLOROPHENYL)METHYL]-4,4-DIMETHYL-3-ISOXAZOLIDINONE-BASED SUSPENSION CONCENTRATES | Bayer Aktiengesellschaft (DE) | 2020-08-26 | — | — | EP | disclosed |
| WO-2019076744-A1 | AQUEOUS [2-(2,4-DICHLOROPHENYL)METHYL]-4,4-DIMETHYL-3-ISOXAZOLIDINONE-BASED SUSPENSION CONCENTRATES | BAYER AKTIENGESELLSCHAFT (DE) | 2019-04-25 | — | — | WO | disclosed |
| EP-2195389-A1 | A METHOD TO IMPROVE THE COLOR ACCEPTANCE OF VISCOSITY STABILIZED LATEX PAINTS | Elementis Specialties, Inc. (US) | 2010-06-16 | — | — | EP | disclosed |
| WO-2009046131-A1 | A METHOD TO IMPROVE THE COLOR ACCEPTANCE OF VISCOSITY STABILIZED LATEX PAINTS | ELEMENTIS SPECIALTIES, INC. (US) | 2009-04-09 | — | — | WO | disclosed |
| US-20090088516-A1 | METHOD TO IMPROVE THE COLOR ACCEPTANCE OF VISCOSITY STABILIZED LATEX PAINTS | ELEMENTIS SPECIALTIES, INC. | 2009-04-02 | — | — | US | disclosed |
| EP-1345492-B1 | HERBICIDE AGENT | BAYER CROPSCIENCE GMBH (DE) | 2006-02-08 | — | — | EP | disclosed |
| US-6693063-B2 | HALOGENATED HYDROXYBENZONITRILE DERIVATIVE WITH SPECIFIC SURFACTANTS | AVENTIS CROPSCIENCE GMBH (DE) | 2004-02-17 | — | — | US | disclosed |
| US-20020115569-A1 | Herbicidal composition | AVENTIS CROPSCIENCE GMBH (DE) | 2002-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240041043-A1 | STORAGE STABLE AQUEOUS SUSPENSION CONCENTRATES | SORD, SDHA, MDH1 | NFE2L2 2653/4885TRPA1 4301/4885CHAT 3326/4885 |
| US-20020115569-A1 | Herbicidal composition | CBR1, DDT, CYP1A1 | NFE2L2 1312/4885TRPA1 687/4885CHAT 1086/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.